Endoscope Market Size, Share, Growth, and Industry Analysis, By Type (Rigid Endoscopy,Flexible Endoscopy,Capsule Endoscopy,Robot-Assisted Endoscopy), By Application (Cardiology,Neuroendoscopy,Epiduroscopy,Gastroenterology,Pulmonology,ENT Surgery,Gynecology), Regional Insights and Forecast to 2035

Endoscope Market Overview

The global Endoscope Market is forecast to expand from USD 44868.89 million in 2026 to USD 48027.66 million in 2027, and is expected to reach USD 82741.64 million by 2035, growing at a CAGR of 7.04% over the forecast period.

The global Endoscope Market comprises over 50 million endoscopic procedures annually, covering specialties like gastrointestinal (34%), urology (15%), orthopedics (9%), and pulmonology (12%). Flexible endoscopes account for around 87% of total devices, while disposable variants contribute approximately 13%.

In the United States, the endoscope market leads with approximately 20 million procedures annually, including 11 million GI endoscopies, 4 million bronchoscopies, and 3.5 million laparoscopies, supported by over 6,200 hospitals. The U.S. also dominates advancements, contributing around 40% of global R&D investment.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Flexible endoscopes comprise approximately 87% of global market share, driving adoption in minimally invasive diagnostics.
• Major Market Restraint: Nearly 47% of facilities in emerging regions lack access to advanced endoscopy systems due to limited infrastructure.
• Emerging Trends: About 39% of new device launches from 2023–2025 feature AI-enabled imaging and augmented reality capabilities.
• Regional Leadership: North America holds 40.9% of market share, Europe 29%, and Asia-Pacific 21% of endoscopy usage distribution.
• Competitive Landscape: Top five manufacturers control roughly 68% of global market share, led by Olympus at 34% and Karl Storz at 14%.
• Market Segmentation: Gastroenterology dominates with 34% of applications, followed by urology 15%, pulmonology 12%, and gynecology 10%.
• Recent Development: Around 45% of major manufacturers launched advanced flexible and robot-assisted endoscopes between 2023–2025.

Endoscope Market Latest Trends

Recent Endoscope Market Trends underscore transformative shifts in device design and application. Flexible endoscopes dominate, with hospital installations comprising over 87%, while disposable endoscopes now represent approximately 13%, driven by infection‑control mandates. 

Endoscope Market Dynamics

The dynamics of the endoscope market are shaped by a combination of accelerating drivers, restraining factors, emerging opportunities, and persistent challenges that directly influence adoption patterns across global healthcare systems. One of the strongest growth drivers is the rising preference for minimally invasive procedures, with more than 22 million laparoscopic and endoscopic surgeries performed worldwide in 2023.

DRIVER

"Rising demand for minimally invasive diagnostics"

Expanding preference for minimally invasive procedures is visible in the nearly 50 million endoscopic procedures executed globally each year for less morbidity and faster recovery. Gastrointestinal procedures contribute 34% of that volume, supported by over 7,000 hospitals using endoscopes and an 87% share held by flexible types.

RESTRAINT

"Infrastructure and cost limitations"

In resource-limited environments, approximately 47% of healthcare facilities face barriers to purchasing advanced endoscopic systems, due to high procurement cost and limited funding. Disposable technology costs and reprocessing infrastructure limitations restrict adoption; reprocessing devices are valued at USD 2.68 billion, but deployment remains uneven globally.

OPPORTUNITY

"Innovation, automation, and regional expansion"

Opportunities abound in AI-assisted diagnostics, capsule and disposable endoscopy expansion, and robotic integration. The flexible endoscope market is forecast to grow from USD 2.42 billion in 2025 to USD 3.75 billion by 2034, an opportunity lifted by automation and safety demands.

CHALLENGE

"Regulatory complexity and procedure standardization"

A major challenge lies in complying with diverse sterilization protocols, AI validation requirements, and multi-national regulatory approvals. Endoscope reprocessing devices incur USD 2.68 billion in equipment size, but consistency in sterilization cycles remains problematic. 

Endoscope Market Segmentation

The Endoscope Market segmentation spans Type (Rigid, Flexible, Capsule, Robot-Assisted) and Application (Gastroenterology, Pulmonology, Cardiological intervention, Neuroendoscopy, Gynecology, ENT, Epiduroscopy). Rigid systems account for around 13%, flexible dominate with 87%, capsule systems represent 8%, and robot-assisted currently hold 5% of device usage volumes.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Rigid Endoscopy: Rigid endoscopes comprise around 13% of total device volumes. Used in orthopedics, ENT, and certain urological procedures, these instruments deliver stable imaging with superior light transmission. Over 5,000 rigid systems are installed annually worldwide, concentrated in surgical suites.

Flexible Endoscopy: Flexible endoscopes dominate with 87% volume share. Over 43 million procedures involve flexible systems annually, spanning gastroenterology, pulmonology, urology, and general surgery. 

Capsule Endoscopy: Capsule endoscopy devices account for approximately 8% of total endoscopy procedures, with over 2.5 million capsule-based exams conducted globally by 2024, up 31% since 2020. These ingestible capsules transmit images while navigating the GI tract, primarily used in small intestine diagnosis. 

Robot-Assisted Endoscopy: Robot-assisted endoscopy holds around 5% of device installations, with growing use in confined anatomical regions. Procedures increased by 26% over five years, supported by enhanced precision and articulation.

BY APPLICATION

Cardiology: Endoscope-assisted cardiology applications include transesophageal echocardiography and intracardiac visualization, essential in electrophysiology and structural heart disease management. Globally, cardiology accounted for about 4–5 percent of total endoscope procedures, equating to nearly 7.6 million procedures in 2024 out of the total 191 million procedures.

Neuroendoscopy: Neuroendoscopy, used in ventricular and skull base surgeries, remains a specialized yet critical field. In 2024, neuroendoscopy contributed approximately 3 percent of all endoscopic procedures, or nearly 5.7 million procedures globally.

Epiduroscopy: Epiduroscopy is widely used in spinal diagnostics, particularly for identifying and treating chronic back pain conditions. In 2024, epiduroscopy accounted for 2 percent of global endoscopic procedures, or nearly 3.8 million cases. About 60 percent of epiduroscopy procedures were performed in specialized pain management centers.

Gastroenterology: Gastroenterology dominates the Endoscope Market Size, representing 69.8 percent of global endoscopy procedures in 2024 equivalent to nearly 133.6 million procedures out of the total 191 million. Gastrointestinal endoscopes accounted for 55.6 percent of flexible endoscopy volume, reflecting their critical role in diagnostics and treatment.

Pulmonology: Pulmonology, especially bronchoscopy, accounted for 16 percent of flexible endoscope procedures in 2024, equaling about 30.6 million procedures worldwide. Single-use bronchoscopes represented 40 percent of procedures in North America and Europe, compared with 15 percent in Asia-Pacific.

ENT Surgery: ENT surgery represented 7–8 percent of global flexible endoscope volume, with around 15 million ENT procedures performed in 2024. Flexible ENT endoscopes comprised 80 percent of devices, while rigid scopes accounted for 20 percent.

Gynecology: Gynecology accounted for 6 percent of global endoscopy procedures in 2024, equating to approximately 11.4 million cases. Procedures included hysteroscopy and laparoscopic gynecological surgeries.

Regional Outlook for the Endoscope Market

Regional performance varies: North America leads with 40.9% procedural share, Europe follows at 29%, Asia-Pacific holds 21%, and Middle East & Africa approximate 8%. North America dominates with advanced imaging, outpatient facility penetration, and GI procedure volume. Europe benefits from structured auction and hospital networks.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America commands 40.9% of global endoscopy procedures, with device valuation around USD 61.06 billion in 2024. The United States alone accounts for 35% of global procedure volume, with 11 million GI and 4 million bronchoscopies. U.S. endoscope device value reached USD 11.6 billion in 2024.

EUROPE

Europe accounts for 29% of global endoscopic procedure volume, supported by regional GDP-led healthcare investment. The endoscope devices market size is estimated near USD 18 billion in 2024, with strong contribution in Germany, UK, France, Italy, and the Netherlands.

ASIA-PACIFIC

Asia-Pacific holds 21% of procedure volume, with rapid expansion in China, India, Japan, and Southeast Asia. The endoscope market reached approximately USD 15 billion in 2024, increasing with GI disease burden. Flexible endoscopes dominate usage by over 75%, capsule procedures exceeded 800,000 annually.

MIDDLE EAST & AFRICA

Middle East & Africa represent 8% of global endoscopy volume, with markets growing in GCC, South Africa, and Egypt. Estimated value exceeds USD 3 billion in 2025. Flexible systems account for around 60% of installations; capsule procedures are emerging with 120,000 exams annually. Reprocessing infrastructure investment reached USD 300 million region-wide.

List of Top Endoscope Companies

• CONMED Corp.
• Medtronic
• Ethicon US, LLC
• PENTAX Medical
• FUJIFILM Holdings Corp.
• Olympus Corp.
• Richard Wolf Medical Instruments
• Boston Scientific Corp.
• Stryker
• Karl Storz GmbH & Co. KG

Olympus: estimated to control around 34% of global endoscope market share, with leading fiber‑optic and flexible endoscopy technologies, including early 4K imaging systems.

Karl Storz: holds approximately 14% of global share, recognized for expertise in rigid endoscope systems and integrated operating room solutions.

Investment Analysis and Opportunities

Investment in the Endoscope Market is accelerating. In 2024–2025, global capital expenditure in endoscope technology is estimated at USD 8 billion, with 30% directed to AI-enhanced imaging systems and 20% toward capsule and disposable technologies. 

New Product Development

Recent Endoscope Market innovations include AI-integrated flexible scopes that achieve 94% diagnostic accuracy, compared to 78% previously. Capsule devices enhanced with dual‑camera systems now offer sixfold image-brightness and have triple-digit procedure growth. 

Five Recent Developments

• 2023: Olympus launched VISERA ELITE III with 4K, infrared, and narrow-band imaging capabilities across EMEA and parts of Asia.
• 2023: Karl Storz expanded its robotic surgery portfolio via acquisition of Asensus Surgical, boosting robot-assisted endoscopy offerings.
• 2024: Medtronic surpassed 4 million PillCam capsule endoscopy units sold, further popularizing capsule diagnostics.
• 2025: The endoscope reprocessing market reached USD 2.68 billion, driven by a shift toward automated reprocessors and digital tracking.
• 2025: North America accounted for 40.9% of endoscopy market share, reinforcing its leadership in demand and technology adoption.

Report Coverage of Endoscope Market

This Endoscope Market Report delivers expansive coverage including type segmentation Rigid (13%), Flexible (87%), Capsule (8%), Robot-Assisted (5%) and application breakdowns: Gastroenterology (34%), Urology (15%), Pulmonology (12%), Gynecology (10%), ENT (8%), Cardiology (7%), Neuroendoscopy (6%).

Endoscope Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 44868.89 Million in 2026
Market Size Value By	USD 82741.64 Million by 2035
Growth Rate	CAGR of 7.04% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Rigid Endoscopy Flexible Endoscopy Capsule Endoscopy Robot-Assisted Endoscopy By Application : Cardiology Neuroendoscopy Epiduroscopy Gastroenterology Pulmonology ENT Surgery Gynecology
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample